TNPSC Thervupettagam

Mammography Screening with Artificial Intelligence (MASAI) Trial

August 9 , 2023 346 days 388 0
  • Retrospective studies have shown promising results using artificial intelligence (AI) to improve mammography screening accuracy and reduce screen-reading workload.
  • However, a randomised trial has not yet been conducted.
  • Planned interim safety analysis of the first randomised trial is investigating the use of AI in a national breast cancer screening programme.
  • It underscores the potential of AI to make mammography screening more accurate and efficient.
  • Interim findings from a cohort of over 80,000 women in Sweden reveal AI-supported screening detected 20% more cancers.
  • The use of AI did not increase false positives (when a mammogram is incorrectly diagnosed as abnormal) and reduced the mammogram reading workload by 44%.
  • Mammography screening supported by artificial intelligence (AI) detected one-fifth more breast cancers compared with standard screening.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories